C. Schilder

694 total citations
16 papers, 523 citations indexed

About

C. Schilder is a scholar working on Pulmonary and Respiratory Medicine, Psychiatry and Mental health and Genetics. According to data from OpenAlex, C. Schilder has authored 16 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Psychiatry and Mental health and 5 papers in Genetics. Recurrent topics in C. Schilder's work include Cancer-related cognitive impairment studies (11 papers), Estrogen and related hormone effects (5 papers) and Breast Cancer Treatment Studies (3 papers). C. Schilder is often cited by papers focused on Cancer-related cognitive impairment studies (11 papers), Estrogen and related hormone effects (5 papers) and Breast Cancer Treatment Studies (3 papers). C. Schilder collaborates with scholars based in Netherlands, Belgium and United States. C. Schilder's co-authors include Sanne B. Schagen, Willem Boogerd, Sabine C. Linn, Chad M. Gundy, L.V.A.M. Beex, Caroline Seynaeve, F. S. van Dam, J.W.R. Nortier, Hilde M. Huizenga and Cornelis JH van de Velde and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Eating Disorders and Psycho-Oncology.

In The Last Decade

C. Schilder

16 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Schilder Netherlands 9 427 238 106 97 82 16 523
Kerstin Hermelink Germany 12 654 1.5× 405 1.7× 259 2.4× 39 0.4× 169 2.1× 28 881
Joyce MacKenzie Canada 13 899 2.1× 643 2.7× 136 1.3× 39 0.4× 191 2.3× 16 991
Angela Stewart Canada 5 504 1.2× 346 1.5× 119 1.1× 39 0.4× 87 1.1× 6 559
Karin Münzel Germany 5 559 1.3× 375 1.6× 137 1.3× 20 0.2× 124 1.5× 7 596
I. Chemerynsky Canada 4 570 1.3× 333 1.4× 294 2.8× 22 0.2× 88 1.1× 6 711
Karen K. Paraska United States 5 331 0.8× 234 1.0× 94 0.9× 21 0.2× 47 0.6× 5 385
Paula Warren United States 9 107 0.3× 177 0.7× 75 0.7× 8 0.1× 81 1.0× 18 492
M. de Groot Netherlands 8 97 0.2× 194 0.8× 30 0.3× 14 0.1× 119 1.5× 13 442
Hanneke Zwinkels Netherlands 7 178 0.4× 379 1.6× 113 1.1× 6 0.1× 168 2.0× 20 562
Douglas J. Hyder United States 7 90 0.2× 228 1.0× 13 0.1× 31 0.3× 18 0.2× 9 397

Countries citing papers authored by C. Schilder

Since Specialization
Citations

This map shows the geographic impact of C. Schilder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Schilder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Schilder more than expected).

Fields of papers citing papers by C. Schilder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Schilder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Schilder. The network helps show where C. Schilder may publish in the future.

Co-authorship network of co-authors of C. Schilder

This figure shows the co-authorship network connecting the top 25 collaborators of C. Schilder. A scholar is included among the top collaborators of C. Schilder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Schilder. C. Schilder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Kieffer, Jacobien M., Brent J. Small, Willem Boogerd, et al.. (2023). Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer. JNCI Cancer Spectrum. 7(2). 6 indexed citations
2.
Molleman, Lucas, et al.. (2022). Can measures of cognitive flexibility and inhibition distinguish forensic psychiatric inpatients from prisoners?. Journal of Forensic Psychiatry and Psychology. 33(3). 371–388. 3 indexed citations
3.
Schilder, C., Lot Sternheim, Emmeke Aarts, Annemarie Elburg, & Unna N. Danner. (2021). Relationships between educational achievement, intelligence, and perfectionism in adolescents with eating disorders. International Journal of Eating Disorders. 54(5). 794–801. 13 indexed citations
4.
Schilder, C., et al.. (2021). Behavioral Inhibition and Activation System Factors in Offenders and Non-Offenders. International Journal of Forensic Mental Health. 21(2). 133–145. 2 indexed citations
5.
Grond, Jeroen van der, C. Schilder, Roos C. van der Mast, et al.. (2020). Cerebellar Grey Matter Volume in Older Persons Is Associated with Worse Cognitive Functioning. The Cerebellum. 20(1). 9–20. 5 indexed citations
6.
Schilder, C., et al.. (2016). Intellectual functioning of adolescent and adult patients with eating disorders. International Journal of Eating Disorders. 50(5). 481–489. 13 indexed citations
7.
Boele, Florien, et al.. (2014). Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer. Menopause The Journal of The North American Menopause Society. 22(1). 17–25. 50 indexed citations
8.
Schilder, C., Suzanne C. van Dijk, W. Meinhardt, F.S.A.M. van Dam, & Sanne B. Schagen. (2011). Cognitief functioneren van prostaatkankerpatiënten die hormonale therapie ondergaan. 15(1). 20–26. 1 indexed citations
9.
Schilder, C., Caroline Seynaeve, Sabine C. Linn, et al.. (2011). Self‐reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side‐study. Psycho-Oncology. 21(5). 479–487. 45 indexed citations
10.
11.
12.
Schilder, C., Caroline Seynaeve, Sabine C. Linn, et al.. (2009). Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors. Critical Reviews in Oncology/Hematology. 76(2). 133–141. 33 indexed citations
13.
14.
Schilder, C., et al.. (2008). [The effect of hormone therapy on cognitive function in patients with breast cancer].. PubMed. 152(9). 494–8. 1 indexed citations
15.
Schilder, C. & Sanne B. Schagen. (2007). Effects of hormonal therapy on cognitive functioning in breast cancer patients: a review of the literature.. PubMed. 59(4). 387–401. 15 indexed citations
16.
Schilder, C., et al.. (2007). Neuropsychological sequelae of tamoxifen and exemestane after AC-chemotherapy in postmenopausal women with early breast cancer. Journal of Clinical Oncology. 25(18_suppl). 566–566. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kerstin Hermelink Breakdown of academic impact, for papers by Joyce MacKenzie Breakdown of academic impact, for papers by Angela Stewart Breakdown of academic impact, for papers by Karin Münzel Breakdown of academic impact, for papers by I. Chemerynsky Breakdown of academic impact, for papers by Karen K. Paraska Breakdown of academic impact, for papers by Paula Warren Breakdown of academic impact, for papers by M. de Groot Breakdown of academic impact, for papers by Hanneke Zwinkels Breakdown of academic impact, for papers by Douglas J. Hyder
Rankless by CCL
2026